Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mysliwiec

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
Plasma fibronectin levels in patients with glomerular proteinuriaA Rydzewski, M Mysliwiec
Transplantation Proceedings|December 1, 2012
Treatment of anemia with erythropoietin-stimulating agents in kidney transplant recipients and chronic kidney disease-another drawback of immunosuppression?J Malyszko, I Glowinska, M Mysliwiec
Transplantation Proceedings|October 28, 2009
A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipientsJ Malyszko, J S Malyszko, M Mysliwiec
Advances in Medical Sciences|September 18, 2009
High plasma endostatin level unaffected by low-molecular weight heparin in hemodialysis patients--a preliminary reportA Rydzewska-Rosolowska, J Borawski, M Mysliwiec
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 2, 2001
Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysisJ Malyszko, J S Malyszko, M Mysliwiec
Transplantation Proceedings|March 3, 2009
Visfatin, a new adipocytokine, is predominantly related to inflammation/endothelial damage in kidney allograft recipientsJ Malyszko, J S Malyszko, M Mysliwiec
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 20, 2002
Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndromeJ Malyszko, J S Malyszko, M Mysliwiec
Polskie Archiwum Medycyny Wewnetrznej|November 1, 1994
[Fibrinolytic and lipid disturbances in patients with nephrotic syndrome]J Małyszko, J S Małyszko, M Mysliwiec
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patientsJ Malyszko, M Pietraszek, W Buczko, et al.
Journal of Cardiovascular Pharmacology|October 1, 1995
Ketanserin lowers erythropoietin concentration in hemodialyzed patients treated with the hormoneJ Borawski, M Mazerska, K Pawlak, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
Plasma fibronectin levels in patients with glomerular proteinuriaA Rydzewski, M Mysliwiec
Transplantation Proceedings|December 1, 2012
Treatment of anemia with erythropoietin-stimulating agents in kidney transplant recipients and chronic kidney disease-another drawback of immunosuppression?J Malyszko, I Glowinska, M Mysliwiec
Transplantation Proceedings|October 28, 2009
A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipientsJ Malyszko, J S Malyszko, M Mysliwiec
Advances in Medical Sciences|September 18, 2009
High plasma endostatin level unaffected by low-molecular weight heparin in hemodialysis patients--a preliminary reportA Rydzewska-Rosolowska, J Borawski, M Mysliwiec
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 2, 2001
Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysisJ Malyszko, J S Malyszko, M Mysliwiec
Transplantation Proceedings|March 3, 2009
Visfatin, a new adipocytokine, is predominantly related to inflammation/endothelial damage in kidney allograft recipientsJ Malyszko, J S Malyszko, M Mysliwiec
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 20, 2002
Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndromeJ Malyszko, J S Malyszko, M Mysliwiec
Polskie Archiwum Medycyny Wewnetrznej|November 1, 1994
[Fibrinolytic and lipid disturbances in patients with nephrotic syndrome]J Małyszko, J S Małyszko, M Mysliwiec
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patientsJ Malyszko, M Pietraszek, W Buczko, et al.
Journal of Cardiovascular Pharmacology|October 1, 1995
Ketanserin lowers erythropoietin concentration in hemodialyzed patients treated with the hormoneJ Borawski, M Mazerska, K Pawlak, et al.
Pageof 9